Riskpilot← Back to searchSign inGet full accessApofri AB
ABDissolvedOrg 5567736847Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20080 employees
Revenue 2022
SEK 34,5M
+34% vs 2021
EBITDA margin
3.5%
+89% vs 2021
Equity ratio
1.8%
Financial strength
Net profit 2022
SEK 2K
-60% vs 2021
| Revenue | SEK 34,5M | +34% |
| EBITDA | SEK 1,2M | +89% |
| Net profit | SEK 2K | -60% |
| Total assets | SEK 6,5M | -41% |
| Equity | SEK 115K | +2% |
| Employees | 0 | — |
Legal name
Apofri AB
Org number
5567736847
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
19 december 2008
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av Karroum, Said Richard
Company purpose
Bolaget skall tillverka och försälja läkemedel, naturmedel, kemiska produkter och medicinsk apparatur samt därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 27 721 | 29 256 | 36 801 | 25 680 | 34 495 |
| Staff expenses | — | — | — | — | — | — | — | — |
| EBITDA | 2 940 | 2 190 | 1 527 | 1 028 | 1 033 | 1 099 | 643 | 1 215 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | 2 940 | 2 190 | 1 527 | 1 028 | 1 033 | 1 099 | 643 | 1 215 |
| Net financials | −227 | −28 | −351 | −362 | −250 | −194 | −6 | −213 |
| Profit before tax | 1 | 0 | 0 | 1 | 0 | 5 | 6 | 2 |
| Tax | −0 | −0 | −0 | −0 | −0 | −1 | −1 | −0 |
| Net profit | 1 | 0 | 0 | 1 | 0 | 4 | 5 | 2 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 27 890 | 18 272 | 11 237 | 7 946 | 9 298 | 7 086 | 11 085 | 6 527 |
| Equity | 103 | 102 | 103 | 104 | 104 | 108 | 113 | 115 |
| Long-term debt | 0 | 6 000 | 6 000 | 6 000 | 0 | 0 | 0 | 0 |
| Short-term debt | 27 787 | 12 170 | 5 134 | 1 842 | 9 194 | 6 978 | 10 972 | 6 412 |
| Total debt | 27 787 | 18 170 | 11 134 | 7 842 | 9 194 | 6 978 | 10 972 | 6 412 |
EBITDA margin
3.5%
This company
15.8%
Market median
-78% vs market
20152022
Equity ratio
1.8%
This company
38.2%
Market median
-95% vs market
20152022
Return on equity
1.7%
This company
18.4%
Market median
-91% vs market
20152022
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20152022
Asset turnover
5.28×
This company
1.12×
Market median
+371% vs market
20152022
Debt / equity
55.76×
This company
0.62×
Market median
-8894% vs market
20152022
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
RN Chief Auditor | Chief Auditor | 2020 | — | — |
SR Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Chairman | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Evolan Pharma AB | Company | 100.0% | 100.0% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Rosemed Holding AB
Apofri AB Board members of Apofri AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Rolf Nicklas Kullberg | Chief Auditor | 0 companies |
| Said Richard Karroum | Chief Executive Officer | 0 companies |
| Ulrika Elisabeth Marie Håkansson | Board of Directors | 0 companies |
| Francois Alexander Karroum | Deputy Board Member | 0 companies |
| Anders Leif Håkansson | Chairman | 0 companies |